Wendi Hu
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine
- Oncology
- Electrical and Electronic Engineering
- Topics
- RNA modifications and cancer (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Cancer, Lipids, and Metabolism (3 papers)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Wendi Hu
22 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 835
- Cancer Research 577
- Pulmonary and Respiratory Medicine 143
- Oncology 141
- Electrical and Electronic Engineering 69
Countries citing papers authored by Wendi Hu
This map shows the geographic impact of Wendi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendi Hu more than expected).
Fields of papers citing papers by Wendi Hu
This network shows the impact of papers produced by Wendi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendi Hu. The network helps show where Wendi Hu may publish in the future.
Co-authorship network of co-authors of Wendi Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Wendi Hu. A scholar is included among the top collaborators of Wendi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendi Hu. Wendi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 18 | |
| 6 | 18 | |
| 7 | 19 | |
| 8 | 162 | |
| 9 | 71 | |
| 10 | WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1breakdown → | 479 |
| 11 | 25 | |
| 12 | 24 | |
| 13 | 16 | |
| 14 | LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells. | 3 |
| 15 | 42 | |
| 16 | 28 | |
| 17 | 1 | |
| 18 | 6 | |
| 19 | 28 | |
| 20 | 61 |
About Wendi Hu
Wendi Hu is a scholar working on Cancer Research, Hepatology and Oncology, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (577 citations), Molecular Biology (835 citations) and Oncology (141 citations). Wendi Hu has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Shusen Zheng, Haiyang Xie, Jian Wu, Chuanhui Peng, Junru Chen, Yunhao Chen, Lin Zhou, Beng Yang, Bin He and Yanpeng Zhang. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.